Trial Profile
Phase I single-center, double-blinded, randomized clinical trial of SB208 16% in female patients with Onychomycosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 May 2018
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Onychomycosis
- Focus Adverse reactions; Therapeutic Use
- 24 May 2018 New trial record
- 17 May 2018 According to the Novan Inc media release, data from this study will be presented at the International Investigative Dermatology meeting 2018.